116 related articles for article (PubMed ID: 31080976)
1. A light-facilitated drug delivery system from a pseudo-protein/hyaluronic acid nanocomplex with improved anti-tumor effects.
Ji Y; Li J; Zhao J; Shan S; Chu CC
Nanoscale; 2019 May; 11(20):9987-10003. PubMed ID: 31080976
[TBL] [Abstract][Full Text] [Related]
2. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complex from cyclodextrin-grafted hyaluronic acid and pseudo protein as biodegradable nano-delivery vehicle for gambogic acid.
Ji Y; Shan S; He M; Chu CC
Acta Biomater; 2017 Oct; 62():234-245. PubMed ID: 28859900
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable nanocomplex from hyaluronic acid and arginine based poly(ester amide)s as the delivery vehicles for improved photodynamic therapy of multidrug resistant tumor cells: An in vitro study of the performance of chlorin e6 photosensitizer.
Ji Y; Zhao J; Chu CC
J Biomed Mater Res A; 2017 May; 105(5):1487-1499. PubMed ID: 27997760
[TBL] [Abstract][Full Text] [Related]
5. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
7. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
[TBL] [Abstract][Full Text] [Related]
8. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
9. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
10. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembly Assisted Fabrication of Dextran-Based Nanohydrogels with Reduction-Cleavable Junctions for Applications as Efficient Drug Delivery Systems.
Wang H; Dai T; Zhou S; Huang X; Li S; Sun K; Zhou G; Dou H
Sci Rep; 2017 Jan; 7():40011. PubMed ID: 28071743
[TBL] [Abstract][Full Text] [Related]
12. A novel redox-sensitive system based on single-walled carbon nanotubes for chemo-photothermal therapy and magnetic resonance imaging.
Hou L; Yang X; Ren J; Wang Y; Zhang H; Feng Q; Shi Y; Shan X; Yuan Y; Zhang Z
Int J Nanomedicine; 2016; 11():607-24. PubMed ID: 26917960
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-modified redox-sensitive hybrid nanocomplex loading with siRNA for non-small-cell lung carcinoma therapy.
Chen D; Zhang P; Li M; Li C; Lu X; Sun Y; Sun K
Drug Deliv; 2022 Dec; 29(1):574-587. PubMed ID: 35156491
[TBL] [Abstract][Full Text] [Related]
14. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
[TBL] [Abstract][Full Text] [Related]
16. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy.
Sun CY; Zhang BB; Zhou JY
J Mater Chem B; 2019 Aug; 7(31):4843-4853. PubMed ID: 31389968
[TBL] [Abstract][Full Text] [Related]
17. Remodeling the tumor microenvironment to improve drug permeation and antitumor effects by co-delivering quercetin and doxorubicin.
Li M; Yue X; Wang Y; Zhang J; Kan L; Jing Z
J Mater Chem B; 2019 Dec; 7(47):7619-7626. PubMed ID: 31746936
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid modified doxorubicin loaded Fe
Gong T; Dong Z; Fu Y; Gong T; Deng L; Zhang Z
J Mater Chem B; 2019 Oct; 7(38):5861-5872. PubMed ID: 31512706
[TBL] [Abstract][Full Text] [Related]
19. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
[TBL] [Abstract][Full Text] [Related]
20. Targeting drug delivery and efficient lysosomal escape for chemo-photodynamic cancer therapy by a peptide/DNA nanocomplex.
Wang Q; He Z; Zhu H; Gao W; Zhang N; Li J; Yan J; He B; Ye X
J Mater Chem B; 2022 Jan; 10(3):438-449. PubMed ID: 34951442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]